Two Sigma Investments’s Alexion Pharmaceuticals ALXN Stock Holding History

Two Sigma Investments’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-57,783	Closed	-$8.84M	–	4987
2021 Q1	$8.84M	Buy	57,783 +41,179	+248%	+$6.37M	0.03%	751
2020 Q4	$2.59M	Buy	16,604 +7,268	+78%	+$934K	0.01%	1325
2020 Q3	$1.07M	Sell	9,336 -50,485	-84%	-$5.45M	﹤0.01%	1708
2020 Q2	$6.71M	Sell	59,821 -297,071	-83%	-$31.5M	0.04%	527
2020 Q1	$32M	Sell	356,892 -26,939	-7%	-$2.64M	0.34%	64
2019 Q4	$41.5M	Buy	383,831 +381,415	+15,787%	+$40.8M	0.15%	180
2019 Q3	$237K	Sell	2,416 -83,200	-97%	-$9.38M	﹤0.01%	3103
2019 Q2	$11.2M	Sell	85,616 -24,776	-22%	-$3.19M	0.04%	548
2019 Q1	$14.9M	Sell	110,392 -97,457	-47%	-$12.1M	0.05%	507
2018 Q4	$20.2M	Buy	207,849 +135,166	+186%	+$16M	0.09%	330
2018 Q3	$10.1M	Sell	72,683 -118,715	-62%	-$14.9M	0.03%	640
2018 Q2	$23.8M	Buy	+191,398	New	+$22.4M	0.08%	360
2017 Q4	–	Sell	-173,418	Closed	-$21.1M	–	3670
2017 Q3	$24.3M	Buy	173,418 +22,617	+15%	+$3.07M	0.09%	286
2017 Q2	$18.3M	Sell	150,801 -278,619	-65%	-$32.4M	0.07%	350
2017 Q1	$52.1M	Buy	+429,420	New	+$55.4M	0.19%	149
2016 Q4	–	Sell	-388,550	Closed	-$47.6M	–	3748
2016 Q3	$47.6M	Sell	388,550 -397,966	-51%	-$51.2M	0.2%	132
2016 Q2	$91.8M	Buy	786,516 +607,547	+339%	+$86.2M	0.44%	51
2016 Q1	$24.9M	Buy	+178,969	New	+$26.3M	0.13%	203
2015 Q4	–	Sell	-363,912	Closed	-$63.6M	–	3176
2015 Q3	$56.9M	Buy	363,912 +312,175	+603%	+$56.9M	0.3%	96
2015 Q2	$9.35M	Sell	51,737 -172,728	-77%	-$29.8M	0.05%	469
2015 Q1	$38.9M	Buy	224,465 +215,639	+2,443%	+$39M	0.19%	150
2014 Q4	$1.63M	Sell	8,826 -26,921	-75%	-$4.99M	0.01%	1121
2014 Q3	$5.93M	Sell	35,747 -19,737	-36%	-$3.24M	0.03%	580
2014 Q2	$8.67M	Sell	55,484 -484,922	-90%	-$76.6M	0.04%	529
2014 Q1	$82.2M	Buy	+540,406	New	+$85.9M	0.44%	38
2013 Q4	–	Sell	-52,553	Closed	-$6.11M	–	2449
2013 Q3	$6.11M	Sell	52,553 -238,045	-82%	-$26.1M	0.04%	477
2013 Q2	$26.8M	Buy	+290,598	New	+$28M	0.19%	147